Drug details
Perjeta (pertuzumab)
type of Antineoplastics Monoclonal Antibody, Antineoplastics, Anti-HER2
Perjeta (pertuzumab) Injection is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
This drug may have the following side effects:
- hives,
- difficulty breathing,
- swelling of your face, lips, tongue, or throat,
- nausea,
- vomiting,
- fever,
- easy bruising,
- unusual bleeding,
- pale skin,
- lightheadedness,
- shortness of breath,
- cold hands and feet,
- confusion,
- chills,
- tiredness,
- dizziness,
- fluttering in your chest,
- headache,
- weakness,
- mouth sores,
- muscle cramps,
- pounding heartbeats,
- new or worsening cough,
- swelling in your lower legs,
- skin sores,
- decreased urination, and
- tingling in your hands and feet or around your mouth
- muscle pain,
- fast or slow heartbeat,
- unusual taste in your mouth,
The following drugs are related to Perjeta, either as a replacement or used together:
- Fosamax (alendronate sodium)
- Fosamax Plus D (alendronate sodium and cholecalciferol)
- Piqray (alpelisib tablets)
- Arimidex (anastrozole)
- Aromasin (exemestane)
- Xeloda (capecitabine)
- Capecitabine (Xeloda) Tablets (capecitabine tablets)
- Cytoxan (cyclophosphamide)
- Ellence (epirubicin hydrochloride)
- Faslodex (fulvestrant)
- Halotestin (fluoxymesterone)
- Herceptin (trastuzumab)
- Kisqali (ribociclib tablets)
- Kisqali FeMara Co-Pack (ribociclib and letrozole tablets)
- Ontruzant (trastuzumab-dttb for injection)
- Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf injection)
- Trodelvy (sacituzumab govitecan-hziy for injection, for iv use)
- Talzenna (talazoparib capsules)